DRTS today
$13.39-$0.63 (-4.46%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourLeaning Bearish
1 hourStrong Bearish
15 minStrong Bearish
5 minDescending Triangle
Daily trend turns up above $14.50
Key levels
Resistance$14.43
Resistance$13.56
Support$12.67
Support$11.99
Latest news & SEC filings
NewsAlpha Tau Medical to Host Call on REGAIN Trial Interim Results
AnalystPiper Sandler lifts Alpha Tau Medical rating to Overweight
AnalystPiper Sandler raises Alpha Tau Medical to Overweight, price target to $22
All DRTS news →About Alpha Tau
Alpha Tau Medical develops a radiation-based cancer treatment called Alpha DaRT, which places Radium-224 sources inside solid tumors to release alpha particles that destroy cancer cells while limiting harm to nearby healthy tissue. The company is running trials for skin, head and neck, pancreatic, brain, prostate, lung, rectal and liver tumors, testing the therapy alone and alongside immunotherapies. It makes its products in Israel and Massachusetts, with a larger production site being built in New Hampshire.
Based on the company's 20-F filed Mar 9, 2026.
Nasdaq · Healthcare
Alpha Tau Medical Ltd. (DRTS)
What Is the Price Target for DRTS?
SEPT Low Target
$8.00
SEPT Mid Target
$16.00
SEPT High Target
$30.00
Analyst Consensus
$16.00
Is DRTS a Buy or Sell Right Now?
Thesis
- •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment rising.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for DRTS.
Start Free Trial →Is DRTS Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$12.62
10
Moat Score
NONE
3/9
Piotroski Score
18.6
Altman Z-Score
What Is Smart Money Doing with DRTS?
Insider Signal
NEUTRAL
0 buys / 2 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Levy Raphi | officer | Sale | 17,500 | $191K | Jun 3, 2026 |
| Levy Raphi | officer | Sale | 15,000 | $161K | Jun 3, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →DRTS Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-17.78%
FCF Growth YoY
-48.8%
Revenue Trend
UNKNOWN
Dark Pool Trades for DRTS
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for DRTS, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 19:40:57 | $13.39 | 1,200 | $$16K | MIDPOINT |
| 18:56:54 | $13.49 | 3,533 | $$48K | BUY |
| 18:32:13 | $13.63 | 1,000 | $$14K | BUY |
| 18:17:27 | $13.59 | 2,000 | $$27K | BUY |
| 17:24:56 | $13.53 | 1,200 | $$16K | BUY |
5 dark pool trades shown · $$121K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for DRTS
PREVIEWSEPT Investing provides real-time options flow tracking for DRTS, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $12.5 | Feb 19 | 99 | $$230 | 1 | SWEEP |
| CALL | $12.5 | Feb 19 | 99 | $$230 | 1 | SWEEP |
| CALL | $12.5 | Feb 19 | 99 | $$230 | 1 | SWEEP |
| CALL | $12.5 | Feb 19 | 99 | $$675 | 3 | SWEEP |
| CALL | $12.5 | Feb 19 | 99 | $$225 | 1 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Alpha Tau Medical Ltd. (DRTS) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →DRTS — frequently asked questions
What is DRTS stock price today?
Alpha Tau Medical Ltd. (DRTS) is at $13.39, down 4.46% (-$0.63) at the Nov 12, 2026 close.
Why is DRTS stock moving today?
Latest DRTS news — Nov 12, 2026: Alpha Tau Medical to Host Call on REGAIN Trial Interim Results · Nov 11, 2026: Piper Sandler lifts Alpha Tau Medical rating to Overweight
What is the DRTS price target?
The average analyst price target for DRTS is $16.00, ranging from $8 to $30, based on 5 analysts.
What do analysts rate DRTS?
Analyst ratings for DRTS: 0 Buy, 11 Hold, 0 Sell — consensus Hold.
Did DRTS beat earnings?
DRTS last reported on Aug 10, 2026: EPS -$0.50 vs -$0.14 expected — a miss of 254.9%.
Does DRTS pay a dividend?
DRTS does not currently pay a dividend.
What are DRTS support and resistance levels?
Support: $12.67, $11.99, $10.96. Resistance: $13.56, $14.43, $15.34.
What are insiders doing with DRTS?
Insider activity: NEUTRAL, 0 buys and 2 sells in the last 90 days.
What is the latest news on DRTS?
Nov 12, 2026: Alpha Tau Medical to Host Call on REGAIN Trial Interim Results · Nov 11, 2026: Piper Sandler lifts Alpha Tau Medical rating to Overweight · Nov 11, 2026: Piper Sandler raises Alpha Tau Medical to Overweight, price target to $22